Life Extension ArthroMAX with Theaflavin & AprsFlex(Not to be sold in Belgium) 120 VegCap
You save: 25% (
ArthroMAX with Theaflavin & AprsFlex Not to be sold in Belgium 120 VegCap
ArthroMax R with Theaflavins & AprsFlex R is one of our ArthroMax R family of joint supplements. It combines five innovative nutrients to support joint and connective tissue health and mobility.
Black tea theaflavins, MSM methylsulfonylmethane , AprsFlex R Indian frankincense Boswellia serrata , glucosamine and boron all support joint health and mobility in different ways. And theyre all included in ArthroMax R with Theaflavins & AprsFlex R , a science-based, vegan-friendly joint health supplement.
ArthroMax R with Theaflavins & AprsFlex R Benefits
Helps maintain comfortable joint function
Inhibits inflammatory factors called cytokines to encourage a healthy inflammatory response
Contains clinically studied ingredients to promote knee joint comfort
Suggested Use As a dietary supplement Take four 4 capsules two capsules in the morning and two capsules in the afternoon with food - Or as directed by your healthcare professional.
Serving Size 4 vegetarian
Servings Per Container 30
Amount Per Serving
% Daily Value***
Glucosamine sulfate 2KCI derived from corn
Black tea theaflavins decaffeinated extract leaf standardized to 12% TF2a fraction 52.8 mg , along with TF-1, TF2b and TF3 theaflavin fractions
AprsFlex R Indian frankincense Boswellia serrata extract gum resin std. to 20% 3-O-acetyl-11-keto-s-boswellic acid AKBA 20 mg
Boron calcium fructoborate as patented FruiteX B OsteoBoron
*Daily Value Not Established ***Percent Daily Values are based on a 2,000 calorie diet
Other Ingredientsvegetable cellulose capsule , microcrystalline cellulose, vegetable stearate, silica.
WarningsKeep out of reach of children. As with all dietary supplements, consult your healthcare professional before use. See product label for more information. AprsFlex R is a registered trademark of Laila Nutraceuticals exclusively licensed to PL Thomas Laila Nutra LLC. U.S. Patent No. 8,551,496 and other patents pending. DO NOT EXCEED RECOMMENDED DOSE